oncoMASTER Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

oncoMASTER General Information

Description

Provider of personalized cancer genetic reporting service intended to deliver treatment recommendations. The company provides genetic mutation information explanations and statistics, drug and clinical information related to genetic variations, analysis of patient clinical data, and continuous updates on cancer-related information, enabling patients to understand genetic conditions, access relevant drug and clinical information, and make informed treatment decisions.

Contact Information

Website
www.onco-master.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Room 305, Biz S Building, Seoul Biohub,117-3 Hoegiro
  • Seoul, 02455
  • South Korea
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Clinics/Outpatient Services
Other Healthcare Technology Systems
Parent Company
Oncocross
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Room 305, Biz S Building, Seoul Biohub,117-3 Hoegiro
  • Seoul, 02455
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

oncoMASTER Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Jul-2026 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator $1.5M Completed Generating Revenue
1. Corporate 07-Feb-2024 $1.5M $1.5M Completed Generating Revenue
To view oncoMASTER’s complete valuation and funding history, request access »

oncoMASTER Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
KU Startup Accelerator/Incubator
Seoul Biohub Accelerator/Incubator
Yuhan Corporation Minority
To view oncoMASTER’s complete investors history, request access »

Ready to get started?

Request a free trial

oncoMASTER FAQs

  • When was oncoMASTER founded?

    oncoMASTER was founded in 2022.

  • Where is oncoMASTER headquartered?

    oncoMASTER is headquartered in Seoul, South Korea.

  • What industry is oncoMASTER in?

    oncoMASTER’s primary industry is Laboratory Services (Healthcare).

  • Is oncoMASTER a private or public company?

    oncoMASTER is a Private company.

  • What is oncoMASTER’s current revenue?

    The current revenue for oncoMASTER is .

  • How much funding has oncoMASTER raised over time?

    oncoMASTER has raised $1.5M.

  • Who are oncoMASTER’s investors?

    KU Startup, Seoul Biohub, and Yuhan have invested in oncoMASTER.

  • When was oncoMASTER acquired?

    oncoMASTER was acquired on 01-Jul-2026.

  • Who acquired oncoMASTER?

    oncoMASTER was acquired by Oncocross.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process